Description: This talk will cover the recent advances in psychiatry for treating many mental illnesses. It will particularly focus on specialized treatments such as ketamine therapy and TMS, as well as other types of treatments in advanced stages of development, such as psychedelics.
Dr. Feifel earned a B.Sc., master’s, Ph.D. (neurobiology) and MD from the University of Toronto, Canada. He then completed an Internal Medicine internship followed by Psychiatry residency training at the University of California, San Diego. Upon finishing his training, he joined the faculty of UCSD Department of Psychiatry. Dr. Feifel has specialty certification in Behavioral Neurology and Neuropsychiatry. At UCSD, Dr. Feifel was Director of the psychiatry inpatient unit. He established and headed the UCSD Adult ADHD program, and he created the Department of Psychiatry’s Center for Advanced Treatments where he introduced several novel treatments such as Transcranial Magnetic Stimulation (TMS) and Ketamine. He was one of the first providers in the country to utilize those treatments. At UCSD, Dr. Feifel also regularly taught undergraduate and medical students, resident doctors and postdoctoral fellows and he headed a NIMH-funded translational research program focused on developing new treatments for psychiatric disorders. He has published more than 130 peer-reviewed scientific papers. His work has been featured in the New York Times, Time magazine, National Public Radio (NPR), New England Journal of Medicine, USA Today, Scientific America, among others. Dr. In 2017 Dr. Feifel established Kadima Neuropsychiatry Institute, a private institute in La Jolla, focusing on innovative treatments such as ketamine therapy, transcranial magnetic stimulation (TMS) and psychedelic assisted therapy for mental illness.